ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy

Wang, Kewei; Xiao, Xuan; Liu, Ye; Zong, Qingyu; Tu, Yalan; Yuan, Youyong*
Biomaterials2022-10DOI: 10.1016/j.biomaterials.2022.121803
5被引5阅读
引用收藏
分享

摘要

Reactive oxygen species (ROS)-activated prodrugs can potentially improve the selectivity of chemotherapeutics. However, the inability to release sufficient drugs at tumor sites due to the paucity of ROS, which is required for prodrug activation usually limits the antitumor potency. Herein, a delivery nanosystem with self-amplifiable drug release pattern is constructed by encapsulating a tumor specificity ROS inducer NAD(P)H: quinone oxidoreductase-1 (NQO1)-responsive hemicyanine fluorescent dye (NCyNH2) in a ROS-responsive self-immola-tive polyprodrug nanoparticle for orchestrated oxidation-chemotherapy. In response to ROS stimulation, the self-immolative polyprodrug can degrade and release doxorubicin (DOX) through a domino-like fragmentation, which can impart advanced attributes of this nanosystem such as minimum cleavage events required and maximum cleavage speed for disintegration. Thus, the NCyNH2-loaded self-immolative polyprodrug nanoparticle (SIPN) could be dissociated in response to endogenous ROS, triggering the release of DOX and NCyNH2. Sub-sequently, the NCyNH2 could be activated by intratumoral overexpressed NQO1 to generate additional ROS, which further induces the amplifiable degradation of self-immolative polyprodrug to release sufficient drugs. The in vitro and in vivo studies consistently demonstrate that SIPN amplifies the drug release efficiency of ROS-responsive polyprodrug by specifically upregulating intratumoral ROS levels, resulting in significant antitumor efficacy with minimal side effects.

学科与关键词

关键词
Self-immolative polyprodrugSelf-amplified drug releaseStimuli-responsiveReactive oxygen speciesOxidation-chemotherapy
相关
加载中…
  • A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy
    Li, Jun; Zong, Qingyu; Zhao, Zhongyi; Yuan, Youyong*Chemical Communications, 2023, 59(21): 3142-3145.
  • Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy
    Zong, Qingyu; Xiao, Xuan; Li, Jisi; Yuan, Youyong*Biomaterials Science, 2022, 10(15): 4228-4234.被引 2
  • Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy
    Liu, Ye; Jiang, Maolin; Tu, Yalan; Wang, Kewei; Zong, Qingyu; Yuan, Youyong*Biomaterials, 2021, 278: 121136.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomaterials
发表日期
2022-10
卷期
第 289 卷
页码
121803
DOI
10.1016/j.biomaterials.2022.121803
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [51873072, 52073101]; Science and Technology Program of Guangzhou [202102010025]; Guangdong Provincial Pearl River Talents Program [2019QN01Y088]; Guangdong Basic and Applied Basic Reuter Foundation [2021A1515110258]; China Postdoctoral Science Foundation [2022M711187]; Special Fund for the Construction of High-level Key Clinical Specialty (Medical Imaging) in Guangzhou; Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine

作者

  • W

    Wang, Kewei (第一作者)

  • X

    Xiao, Xuan

查看全部 6 位作者收起作者
  • L

    Liu, Ye

  • Z

    Zong, Qingyu

  • T

    Tu, Yalan

  • Y

    Yuan, Youyong (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417